About
Medibiofarma is a biotechnology company that discovers and develops new chemical entities targeting complex diseases such as cancer, Crohn's disease, and neurodegeneration, focusing on medicinal chemistry and clinical proof-of-concept.
Explore Medibiofarma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.